E-LIB Suche - Ergebnisse für: Gori, N.

1

Analysis of predictive factors influencing dupilumab contin..:

Gori N ; Sernicola A ; Tolino E...
info:eu-repo/semantics/altIdentifier/pmid/37400981. , 2023

Link: https://hdl.handle.net/1..

2

Comorbidities and treatment patterns in adult patients with..:

Campanati A ; Bianchelli T ; Gesuita R...
info:eu-repo/semantics/altIdentifier/pmid/34100126. , 2022

Link: https://hdl.handle.net/1..

3

Therapeutic Impact and Management of Persistent Head and Ne..:

Chiricozzi A ; Gori N ; Di Nardo L...
info:eu-repo/semantics/altIdentifier/pmid/34710866. , 2022

Link: https://hdl.handle.net/1..

4

Dupilumab therapy of atopic dermatitis of the elderly: a mu..:

Patruno C ; Napolitano M ; Argenziano G...
info:eu-repo/semantics/altIdentifier/pmid/33332697. , 2021

Link: https://hdl.handle.net/1..

5

Comorbidities and treatment patterns in adult patients with..:

Campanati A ; Bianchelli T ; Gesuita R...
info:eu-repo/semantics/altIdentifier/pmid/34100126. , 2021

Link: http://hdl.handle.net/11..

6

Management of patients with atopic dermatitis undergoing sy..:

Chiricozzi A ; Talamonti M ; De Simone C...
info:eu-repo/semantics/altIdentifier/pmid/34152613. , 2021

Link: http://hdl.handle.net/24..

7

Management of patients with atopic dermatitis undergoing sy..:

Chiricozzi A ; Talamonti M ; De Simone C...
info:eu-repo/semantics/altIdentifier/pmid/34152613. , 2021

Link: http://hdl.handle.net/11..

8

Disease Severity Is Associated with Alexithymia in Patients..:

Chiricozzi, A ; Esposito, M ; Gisondi, P...
info:eu-repo/semantics/altIdentifier/pmid/32369808. , 2020

Link: https://hdl.handle.net/1..

9

Supplementary Material for: Successful Combination of Syste..:

Gori N. (8800205) ; Chiricozzi A. (5134007) ; Malvaso D. (10015646)...
https://figshare.com/articles/dataset/Supplementary_Material_for_Successful_Combination_of_Systemic_Agents_for_the_Treatment_of_Atopic_Dermatitis_Resistant_to_Dupilumab_Therapy/13621808. , 2021

Link: https://doi.org/10.6084/..

10

Supplementary Material for: Therapeutic Impact and Manageme..:

Chiricozzi A. (5134007) ; Gori N. (8800205) ; DiNardo L. (11617585)...
https://figshare.com/articles/dataset/Supplementary_Material_for_Therapeutic_Impact_and_Management_of_Persistent_Head_and_Neck_Atopic_Dermatitis_in_Dupilumab-Treated_Patients/16895011. , 2021

Link: https://doi.org/10.6084/..

11

Switching to dual/monotherapy determines an increase in CD8..:

Mussini C ; Lorenzini P ; Cozzi-Lepri A...
info:eu-repo/semantics/altIdentifier/pmid/29807541. , 2018

Link: http://hdl.handle.net/11..

12

Switching to dual/monotherapy determines an increase in CD8..:

Mussini C ; Lorenzini P ; Cozzi-Lepri A...
info:eu-repo/semantics/altIdentifier/pmid/29807541. , 2018

Link: http://hdl.handle.net/21..

13

Switching to dual/monotherapy determines an increase in CD8..:

Mussini C ; Lorenzini P ; Cozzi-Lepri A...
info:eu-repo/semantics/altIdentifier/pmid/29807541. , 2018

Link: http://hdl.handle.net/11..

14

Switching to dual/monotherapy determines an increase in CD8..:

Mussini, C ; Lorenzini, P ; Cozzi-Lepri, A...
info:eu-repo/semantics/altIdentifier/pmid/29807541. , 2018

Link: http://hdl.handle.net/11..

15

Switching to dual/monotherapy determines an increase in CD8..:

Mussini, C ; Lorenzini, P ; Cozzi-Lepri, A...
info:eu-repo/semantics/altIdentifier/pmid/29807541. , 2018

Link: http://hdl.handle.net/11..